Zhangzhou Pientzehuang Pharmaceutical (600436.SH) announced that the company intends to participate in the investment of Zhangzhou Yuanshan Healthcare Industry Investment Fund partnership enterprise...
According to the announcement, the company's wholly-owned subsidiary Zhangzhou Pientzehuang Investment Management Co., Ltd. (referred to as "Pientzehuang Investment") intends to subscribe and contribute RMB 0.2 billion as a limited partner with its own or self-raised funds, accounting for 20% of the target fundraising scale of the industry fund.
Zhongtong Finance APP News, Pientzehuang (600436.SH) announced that the company intends to participate in the investment of the Zhangzhou Yuanshan Healthcare Industry Investment Fund partnership enterprise (limited partnership) (tentative name), the industry fund mainly invests in traditional Chinese medicine, biomedical, medical instruments, medical services, health care, cosmetics and other related industries.
The announcement stated that the establishment of the industrial fund for this investment is a forward-looking layout for the company's strategic development. On the premise of ensuring the steady development of the company's main business, with the investment of the fund as a leverage, fully leveraging the resources, management and platform advantages of professional investment institutions, accelerating the gathering of the pharmaceutical industry, enhancing the company's integration capacity upstream and downstream of the industrial chain, achieving resource sharing and complementary advantages, further inspiring innovation vitality, and improving the company's core competitiveness.